Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 18

Results For "IND"

8087 News Found

Inter-ministerial study to track zoonotic spillover risks in India
Public Health | April 17, 2026

Inter-ministerial study to track zoonotic spillover risks in India

One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations


India pushes policy action on adolescent nutrition as obesity concerns rise
Public Health | April 17, 2026

India pushes policy action on adolescent nutrition as obesity concerns rise

ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments


Burnett Homoeopathy hosts global summit at British parliament, amplifies India’s healthcare voice
Healthcare | April 17, 2026

Burnett Homoeopathy hosts global summit at British parliament, amplifies India’s healthcare voice

4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration


Telangana launches Project Sanjeevani, India’s first integrated highway trauma rescue protocol on NH-44
News | April 16, 2026

Telangana launches Project Sanjeevani, India’s first integrated highway trauma rescue protocol on NH-44

Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response


Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy
News | April 16, 2026

Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy

Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%


India chairs first BRICS Health Working Group meet
Policy | April 16, 2026

India chairs first BRICS Health Working Group meet

Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation


Aurobindo’s TheraNym to invest up to $175 million in expanded biologics deal with MSD
Biopharma | April 16, 2026

Aurobindo’s TheraNym to invest up to $175 million in expanded biologics deal with MSD

TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility


India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs
Biotech | April 16, 2026

India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs

Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments


Avantor India expands strategic collaboration with Parafilm to strengthen access to lab consumables
R&D | April 15, 2026

Avantor India expands strategic collaboration with Parafilm to strengthen access to lab consumables

Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users


MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price
Drug Approval | April 15, 2026

MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price

CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing